Study by New York Genome Center and IBM Demonstrates Potential for AI and Whole Genome Sequencing to Scale Access to Precision Medicine
12/07/2017
The proof of concept study used a beta version of Watson for Genomics technology to help interpret whole genome sequencing (WGS) data for one patient. In the study, Watson was able to provide a report of potential clinically actionable insights within 10 minutes, compared to 160 hours of human analysis and curation required to arrive at similar conclusions for this patient.
The study also showed that WGS identified more clinically actionable mutations than the current standard of examining a limited subset of genes, known as a targeted panel. WGS currently requires significantly more manual analysis, so combining this method with artificial intelligence could help doctors identify potential therapies from WGS for more patients in less time.
Interpretation of genome sequencing data is a significant challenge because of the volume of genomic data to sift through, as well as the large, growing body of research on molecular drivers of cancer and potential targeted therapies. This informatics challenge is often a critical bottleneck when dealing with deadly cancers such as glioblastoma, with a median survival of less than 15 months following diagnosis.
Our partnership has explored cutting-edge challenges and opportunities in harnessing genomics to help cancer patients. We provide initial insights into two critical issues: what clinical value can be extracted from different commercial and academic cancer genomic platforms, and how to think about scaling access to that value, noted the study's Principal Investigator, Robert Darnell, MD, PhD, Robert and Harriet Heilbrunn Professor and Senior Attending Physician at The Rockefeller University and Founding Director of the New York Genome Center.
In the study, NYGC researchers and bioinformatics experts analyzed DNA and RNA from a glioblastoma tumor specimen and DNA from the patient's normal blood, and compared potentially actionable insights to those derived from a commercial targeted panel that had previously been performed. The whole genome and RNA sequencing data were analyzed by a team of bioinformaticians and oncologists at the NYGC as well as a beta version of IBM Watson for Genomics, an automated system for prioritizing somatic variants and identifying potential therapies.
The beta version of Watson for Genomics processed abstracts and in some cases, full text articles from PubMed, a comprehensive source of more than 27 million citations for biomedical literature. With this information, the NYGC and Watson collaborated to identify gene alterations that can be therapeutically targeted.
This study documents the strong potential of Watson for Genomics to help clinicians scale precision oncology more broadly, said Vanessa Michelini, Watson for Genomics Innovation Leader, IBM Watson Health. Clinical and research leaders in cancer genomics are making tremendous progress towards bringing precision medicine to cancer patients, but genomic data interpretation is a significant obstacle, and that's where Watson can help.
The study was part of the NYGC's and its Institutional Founding Members' ongoing efforts to advance the use of next-generation sequencing, particularly WGS, in precision medicine. The NYGC and its founding member institutions are conducting additional studies involving Watson to help accelerate the discovery of potentially actionable sequence variants in various types of cancer, including an ongoing study that involves DNA and RNA from a larger cohort of glioblastoma patients, and a study of 200 patients with different types of cancer.
This study, conducted from 2015-2016, utilized a beta version of Watson for Genomics, which is now commercially available for genomic data interpretation through partnerships with Quest Diagnostics, Illumina, or as a cloud-based software for clinicians and researchers. Watson for Genomics is also used in clinical practice at the VA Health System.
About the New York Genome Center
The New York Genome Center is an independent, nonprofit academic research institution at the forefront of transforming biomedical research with the mission of advancing clinical care. A collaboration of premier academic, medical and industry leaders across the globe, the New York Genome Center has as its goal to translate genomic research into the development of new treatments, therapies and therapeutics against human disease. NYGC member organizations and partners are united in this unprecedented collaboration of technology, science and medicine, designed to harness the power of innovation and discoveries to advance genomic services. Their shared objective is the acceleration of medical genomics and precision medicine to benefit patients around the world. For more information, visit our website at http://www.nygenome.org.
Member institutions include: Albert Einstein College of Medicine, American Museum of Natural History, Cold Spring Harbor Laboratory, Columbia University, Hospital for Special Surgery, The Jackson Laboratory, Memorial Sloan Kettering Cancer Center, Icahn School of Medicine at Mount Sinai, NewYork-Presbyterian Hospital, The New York Stem Cell Foundation, New York University, Northwell Health, Princeton University, The Rockefeller University, Roswell Park Cancer Institute, Stony Brook Uni
More from IBM
05/04/2024
IBM and The Government of Spain Collaborate to Advance National AI strategy and Build the World's Leading Spanish Language AI Models
Madrid, Spain April 5, 2024 The President of the Government, Pedro S nchez, ...
26/03/2024
IBM Announces EMEA Geography Winners of the 2024 IBM Partner Plus Awards
London, UK, March 26, 2024 Today, IBM (NYSE: IBM) announced the EMEA geography winners of the 2024 IBM Partner Plus Awards, which celebrate IBM partners who a...
21/02/2024
IBM Report: Cybercriminals Intensify Attacks on User Identities in the UK, Complicating Recovery Efforts for Enterprises
LONDON, UK, Feb 21, 2024 IBM today released the 2024 X-Force Threat Intelligen...
06/02/2024
New IBM LinuxONE 4 Express to Offer Cost Savings and Client Value through a Cyber Resilient Hybrid Cloud and AI Platform
LONDON, U.K., February 6, 2024 IBM (NYSE: IBM) today announced IBM LinuxONE 4 ...
18/01/2024
IBM to Acquire Application Modernization Capabilities from Advanced
Today, IBM is announcing that it has signed a definitive agreement to acquire application modernization capabilities from Advanced, bringing a combination of ta...
10/01/2024
UK Lags Leading Asian Economies on Enterprise AI Adoption - New IBM Study
LONDON and ARMONK, N.Y., January 10, 2024 New research commissioned by IBM (NYSE: IBM) found that more than a third of UK organisations with over 1,000 employ...
13/12/2023
NATO Selects IBM to Further Enhance Alliance's Cybersecurity Resilience
LONDON, UK, December 13, 2023 - Today, IBM (NYSE: IBM) signed a contract with the NATO Communications and Information Agency (NCI Agency) to help strengthen the...
05/12/2023
AWS Announces IBM Winner of the 2023 Global Systems Integrator Partner of the Year Award
LONDON, UK, 5 December, 2023 Amazon Web Services, Inc. (AWS), an Amazon.com co...
30/11/2023
IBM Advances Geospatial AI to Address Climate Challenges
LONDON, UK, Nov 30, 2023 IBM (NYSE: IBM) today announced new efforts that apply its geospatial AI technologies, including IBM's geospatial foundation mode...
22/11/2023
IBM Commits to Train 2 Million in Artificial Intelligence in Three Years, with a Focus on Underrepresented Communities
DUBLIN, 22 November, 2023 - To help close the global artificial intelligence (AI...
08/11/2023
New IBM Study Explores the Changing Role of Leadership as UK Businesses Embrace Generative AI
Wednesday 8 November, London: Today, IBM launched its new report Leadership in ...
27/10/2023
The Sunday Times: Why Big Blue is betting on an AI reboot
Arvind Krishna, Chairman and CEO of IBM, met recently with one of the UK's leading business editors in New York for a major profile interview. The Sunday T...
18/10/2023
IBM Expands Relationship with AWS to Bring Generative AI Solutions and Dedicated Expertise to Clients
LONDON, UK, October 18, 2023: IBM (NYSE: IBM) today announced an expansion of it...
13/09/2023
IBM Announced as Sponsor of 2023 U.N. Climate Change Conference (COP28)
LONDON, UK, September 13, 2023 IBM (NYSE: IBM) today announced its role as an Associate Pathway Partner of the 2023 United Nations Climate Change Conference (...
17/08/2023
IBM Consulting Collaborates with Microsoft to Help Companies Accelerate Adoption of Generative AI
LONDON, UK, August 17, 2023 - Today, IBM (NYSE: IBM) is expanding its collaborat...
14/08/2023
IBM Study: AI Drives Massive Shifts in Jobs and Skills as Employees Prioritise Meaningful Work
LONDON, UK, August 14, 2023 - Executives in the UK estimate that 41% of their wo...
24/07/2023
IBM Security Report: Cost of a Data Breach for UK Businesses Averages 3.4m
LONDON, UK. 24 July 2023 IBM Security today released its annual Cost of a Data Breach Report,1 which revealed that UK organisations pay an average of £3.4m fo...
20/07/2023
Crown Commercial Service and IBM Sign 3-Year Memorandum of Understanding to Boost Public Sector Services
The Crown Commercial Service (CCS) has announced a new 3-year Memorandum of Unde...
18/07/2023
Digital Realty Selects IBM Sustainability Software to Transform Data into Insights Across its Global Data Centers and Offices
LONDON, UK; July 18, 2023London, UK; July 18, 2023 - IBM (NYSE:IBM) today announ...
27/06/2023
IBM Study: CEOs Embrace Generative AI as Productivity Jumps to the Top of their Agendas
LONDON, UK, June 27, 2023 A new study by the IBM (NYSE: IBM) Institute for Bus...
21/06/2023
IBM Brings Generative AI Commentary and AI Draw Analysis to the Wimbledon Digital Experience
LONDON, U.K. and ARMONK N.Y., June 21, 2023 IBM (NYSE: IBM) and The All Englan...
19/05/2023
Diageo partners with IBM Consulting and SAP to drive its digital transformation initiative
IBM Consulting has been selected to revolutionise Diageo's IT environment by...
23/04/2023
IBM statement on the Confederation of British Industry
You may have seen recent media coverage relating to the Confederation of British Industry (CBI), the largest business association in the UK. IBM agrees with th...
17/04/2023
New IBM Study Reveals Inadequate Data Hinders Progress Against Environmental, Social and Governance Goals
LONDON, UK, April 17, 2023 - A new global IBM (NYSE: IBM) Institute for Business...
03/04/2023
IBM Statement on UK Government's AI Regulation White Paper
IBM is pleased to see the UK government making progress on its plans to develop a pro-innovation approach to AI regulation. Like similar approaches in Singapore...
14/03/2023
IBM launches RFP to help accelerate global water management solutions for vulnerable populations
LONDON, UK, March 1, 2023 - IBM (NYSE: IBM) announced today that it is accepting...
01/03/2023
IBM and Chief Study Finds Women in Leadership Pipeline has Hollowed Out in the Middle
LONDON, UK, March 1, 2023 - The leadership pipeline for women has hollowed out i...
22/02/2023
IBM Report: Vulnerable UK energy system among top targets for cybercriminals as businesses face growing extortion threat
ARMONK, N.Y. and LONDON, UK, FEBRUARY 22, 2023 IBM Security (NYSE: IBM) today ...
14/02/2023
New IBM survey reveals the greatest perceived barrier to professional or technical skill development is that programs are too expensive
London, 14th February 2023 Job seekers, students, and career changers around t...
09/01/2023
Nicola Hodson named Chief Executive, IBM in the UK and Ireland
London, 9 January 2023 IBM today announced that Nicola Hodson has been named Chief Executive, IBM in the UK and Ireland. Dr Hodson succeeds Sreeram Visvanatha...
28/11/2022
East and North Hertfordshire NHS Trust Launches New Virtual Assistant with IBM Watson to Support Human Resources and Bolster Employee Services
Stevenage, UK, November 28th 2022: East and North Hertfordshire NHS Trust is tod...
25/10/2022
IBM Grants $500,000 in-kind to City of Dublin Education Training Board To Boost Cybersecurity Preparedness
October 25, 2022 - As schools become more dependent on technology, ransomware at...
28/09/2022
UK Business Leaders Say Hybrid Cloud is Critical to Modernisation, Yet Security, Skills and Compliance Concerns Impede Success
ARMONK, N.Y., September 28, 2022 New market research from IBM (NYSE: IBM) reve...
31/08/2022
REPROCELL, IBM and STFC harness the power of AI in drug discovery and precision medicine
Glasgow, UK and Daresbury, UK: REPROCELL Europe Ltd, IBM Research and STFC today...
27/07/2022
IBM Report: Consumers Pay the Price as Data Breach Costs Reach All-Time High
CAMBRIDGE, Mass., July 27, 2022 IBM Security today released the annual Cost of a Data Breach Report,[1] revealing costlier and higher-impact data breaches tha...
21/06/2022
IBM Reveals New AI and Cloud Powered Fan Experiences for Wimbledon 2022
London, 21st June, 2022 IBM (NYSE: IBM) and the All England Lawn Tennis Club today unveil new ways for Wimbledon fans around the world to experience The Champ...
18/05/2022
IBM Study: Skills Shortage Stalls UK's AI Adoption as Europe Accelerates
London, 18th May 2022 A global study from IBM (NYSE: IBM) has revealed UK businesses are not progressing their use of artificial intelligence (AI) at the same...
10/05/2022
IBM Study: Sustainability Ranks Among Highest Priorities on CEO Agendas, Yet Lack of Data Insights Hinders Progress
IBM Study: Sustainability Ranks Among Highest Priorities on CEO Agendas, Yet Lac...
13/07/2020
From Studio to Screen: How IBM Developed a Digital Showcase for Final-Year Students at University of the Arts London
From Studio to Screen: How IBM Developed a Digital Showcase for Final-Year Stude...
25/09/2019
CICS 50th Anniversary
CICS 50th Anniversary 19 September, 2019 | Written by: Nick Garrod...
18/09/2019
Rugby Football Union, IBM delivering a refreshed digital experience
Rugby Football Union, IBM delivering a refreshed digital experience 16 August, 2019 | Written by: John Kaduthodil Staying relevant, maintaining and exceedin...
18/09/2019
IBM's Internship program is helping Marwell Zoo improve its recycling with smart technology
IBM's Internship program is helping Marwell Zoo improve its recycling with s...
09/07/2019
IBM Closes Landmark Acquisition of Red Hat for $34 Billion; Defines Open, Hybrid Cloud Future
London - 09 Jul 2019: - Acquisition positions IBM as the leading hybrid cloud p...
03/07/2019
Moorfields Eye Hospital launches first virtual assistant to connect with patients
London - 02 Jul 2019: Moorfields Eye Hospital NHS Foundation Trust (Moorfields)...
13/06/2019
Wimbledon & IBM Herald The Role of AI to Maintain a Competitive Advantage in Sports Landscape
London, UK - 13 Jun 2019: The All England Lawn Tennis Club (AELTC) and IBM toda...
14/02/2019
SPF Private Clients introduces its First AI Mortgage Advisor Built on IBM Watson and IBM Cloud
London, UK - 14 Feb 2019: Ava was created to handle the significant increase in...
07/12/2018
University of Liverpool and IBM sign a Joint Study Agreement for Research and Innovation
London, UK - 28 Nov 2018: A major part of this new relationship is the Joint St...